lutetium has been researched along with triazoles in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, S; Chakraborty, S; Das, T; Kagiya, VT; Mukherjee, A; Nair, CK; Samuel, G; Sarma, HD; Venkatesh, M | 1 |
| Adam, MJ; Bailey, GA; Boros, E; Ferreira, CL; Lacasse, MJ; Lewis, JS; Orvig, C; Patrick, BO; Price, EW; Zeglis, BM | 1 |
| Huxol, E; Mindt, TL; Valverde, IE | 1 |
| Fischer, CA; Mascarin, A; Mindt, TL; Valverde, IE; Vomstein, S | 1 |
| Mascarin, A; Mindt, TL; Valverde, IE; Vomstein, S | 1 |
| Almobarak, B; Altiparmak, G; Arvidsson, Y; Elf, AK; Elias, E; Forssell-Aronsson, E; Hofving, T; Johanson, V; Kristiansson, E; Nilsson, O; Sandblom, V; Shubbar, E; Swanpalmer, J | 1 |
| Behe, M; Grob, NM; Mindt, TL; Schibli, R; Schmid, S | 1 |
7 other study(ies) available for lutetium and triazoles
| Article | Year |
|---|---|
Preparation and preliminary biological evaluation of a 177Lu labeled sanazole derivative for possible use in targeting tumor hypoxia.
Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Fibrosarcoma; Hypoxia; Lutetium; Mice; Neoplasms; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Triazoles | 2004 |
H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu.
Topics: Animals; Aza Compounds; Chelating Agents; Coordination Complexes; Copper Radioisotopes; Crystallography, X-Ray; Female; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Lutetium; Mice; Mice, Nude; Models, Molecular; Molecular Structure; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Triazoles | 2012 |
Radiolabeled antagonistic bombesin peptidomimetics for tumor targeting.
Topics: Amino Acid Sequence; Bombesin; Cell Line, Tumor; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Lutetium; Male; Peptide Fragments; Peptidomimetics; Prostatic Neoplasms; Proteolysis; Radioisotopes; Tomography, Emission-Computed, Single-Photon; Triazoles | 2014 |
Probing the Backbone Function of Tumor Targeting Peptides by an Amide-to-Triazole Substitution Strategy.
Topics: Amides; Animals; Bombesin; Cell Line, Tumor; Heterografts; Humans; Lutetium; Mice, Nude; Neoplasm Transplantation; Peptide Fragments; Peptidomimetics; Proteolysis; Radiopharmaceuticals; Receptors, Bombesin; Structure-Activity Relationship; Tissue Distribution; Triazoles | 2015 |
1,2,3-Triazole Stabilized Neurotensin-Based Radiopeptidomimetics for Improved Tumor Targeting.
Topics: Animals; Antineoplastic Agents; Chemistry Techniques, Synthetic; Cycloaddition Reaction; Female; Half-Life; HT29 Cells; Humans; Isotope Labeling; Lutetium; Mice, Nude; Molecular Targeted Therapy; Neurotensin; Peptide Fragments; Peptidomimetics; Radioisotopes; Receptors, Neurotensin; Structure-Activity Relationship; Tissue Distribution; Triazoles; Xenograft Model Antitumor Assays | 2015 |
177Lu-octreotate therapy for neuroendocrine tumours is enhanced by Hsp90 inhibition.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Female; HSP90 Heat-Shock Proteins; Humans; Lutetium; Male; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neuroendocrine Tumors; Octreotide; Radiopharmaceuticals; Triazoles; Tumor Cells, Cultured | 2019 |
Design of Radiolabeled Analogs of Minigastrin by Multiple Amide-to-Triazole Substitutions.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Design; Gastrins; Humans; Lutetium; Mice; Neoplasms; Peptidomimetics; Protein Binding; Radioisotopes; Radiopharmaceuticals; Receptor, Cholecystokinin B; Triazoles | 2020 |